Schedule 13G ownership disclosure

CRESCENT BIOPHARMA INC.

Ordinary Shares, par value $0.001 per share · CUSIP: 38000Q201

Event date: 2025-10-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • 1Globe Capital LLC

    Shares: 1,425,432.00 · Class: 10.3%

  • Jiaqiang Li

    Shares: 1,425,432.00 · Class: 10.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-014932
Form type
SCHEDULE 13G/A
Filer
1Globe Capital LLC
CIK
CIK 1562189
Filed
Oct 14, 2025
Reporting period
Oct 07, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub